Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 122 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: SWOG Cancer Research Network
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Om Research Llc — Lancaster, California (7.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Chagas Disease
Phase 2
Interventional 130 participants sought
Olive View UCLA Educ and Res Ins — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9921 — Lancaster, California (7.4 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Olive View UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.
Treponema Pallidum, Treponema Pallidum Infection
N/A
Observational 1,000 participants sought
Chemidox Clinical Trials California — Lancaster, California (7.4 mi)
· Sponsor: American Laboratory Products Company
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Om Research LLC ( Site 5038) — Lancaster, California (7.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (7.4 mi)
· Sponsor: Akero Therapeutics, Inc
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (1.2 mi)
· Sponsor: BioStem Technologies
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Amicis Research Corporate — Santa Clarita, California (28.6 mi)
· Sponsor: Boehringer Ingelheim
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2
Interventional 82 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Multiple Sclerosis
Phase 3
Interventional 160 participants sought
Chemidox Clinical Trials- Site Number : 8401157 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Chugai Pharmaceutical
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Chronic Spontaneous Urticaria
Phase 2
Interventional 200 participants sought
Antelope Valley Clinical Trials — Lancaster, California (7.4 mi)
· Sponsor: Pfizer
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (1.2 mi)
· Sponsor: Rapport Therapeutics Inc.
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1142 — Lancaster, California (7.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 131 — Lancaster, California (7.4 mi)
· Sponsor: Locus Biosciences
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Eosinophilic Asthma
Phase 2
Interventional 264 participants sought
Kymera Investigative Site — Lancaster, California (7.4 mi)
· Sponsor: Kymera Therapeutics, Inc.
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Suicide, Suicidal
Phase 2
Interventional 1,600 participants sought
Olive View UCLA Education and Research Center — Sylmar, California (27.8 mi)
· Sponsor: University of California, Los Angeles
Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
End-Stage Renal Disease
N/A
Observational 100 participants sought
Olive View - UCLA Medical Center — Sylmar, California (27.8 mi)
· Sponsor: LifeNet Health
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: NRG Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company